Cell Surface Marker Detection Global Market Report 2025

Cell surface marker detection involves the classification of cells based on their markers, which are proteins expressed on the cell surface or carbohydrates linked to the cell membrane. These markers serve as unique identifiers for specific cell types, akin to fingerprints. This process is valuable for categorizing cells based on their distinct markers.

The primary products associated with cell surface marker detection include flow cytometry, hematology analyzers, and various reagents and kits. Flow cytometry is a laboratory test that analyzes the properties of cells or particles suspended in fluid. During the procedure, a sample is injected into a flow cytometer machine, and a computer can rapidly evaluate and process a large number of cells. Flow cytometry is commonly used to assess bone marrow, peripheral blood, and other bodily fluids, playing a crucial role in disease diagnosis, diseases identification, drug discovery research, and cytological academic research. These products are utilized by a range of entities, including pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, among others. They contribute significantly to advancements in medical research, diagnostics, and drug development.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cell surface marker detection market research report is one of a series of new reports from The Business Research Company that provides cell surface marker detection market statistics, including cell surface marker detection industry global market size, regional shares, competitors with a cell surface marker detection market share, detailed cell surface marker detection market segments, market trends and opportunities, and any further data you may need to thrive in the cell surface marker detection industry. This cell surface marker detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell surface marker detection market size has grown strongly in recent years. It will grow from $5.91 billion in 2024 to $6.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to expansion in biomedical research, evolution of high-content screening, increased chronic disease prevalence, shift towards immunotherapy.

The cell surface marker detection market size is expected to see rapid growth in the next few years. It will grow to $9.75 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to market expansion in emerging economies, expanding biopharmaceutical sector, adoption of single-cell analysis, rise in chronic and infectious diseases, increasing funding for life sciences research. Major trends in the forecast period include advancements in biotechnology, product innovations, technological innovations in flow cytometry, rising prevalence of chronic diseases.

The forecast of 11.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fluorochrome-conjugated antibodies and flow cytometry compensation beads, sourced from key regions such as Japan and Brazil, which could lead to reduced immunophenotyping accuracy and higher diagnostic costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of oncology diseases is set to drive the growth of the cell surface marker detection market. Oncology, characterized by uncontrolled cell growth and spread, has seen a rise attributed to factors like Western lifestyles, poor dietary habits, pollution, and a lack of exercise. Cell surface marker detection plays a crucial role in predicting patient responses to cancer drugs, aiding in point-of-care decisions. Macmillan Cancer Support's October 2022 estimate indicated 3 million people with cancer in 2020, projected to increase to 5.3 million by 2040. This surge in oncology diseases underlines the demand for cell surface marker detection in the market.

The growth of chronic diseases is anticipated to further propel the cell surface marker detection market. Chronic diseases, persistent medical conditions progressing slowly over time, are on the rise globally. Cell surface marker detection contributes to the diagnosis, monitoring, and treatment of chronic diseases, enabling targeted and personalized care. The World Health Organization's September 2022 data highlighted 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases. The prevalence of chronic diseases, including cardiovascular diseases, cancer, respiratory diseases, and diabetes, is a significant driver for the cell surface marker detection market.

Leading companies in the cell surface marker detection market are investing in advanced technologies, such as innovative fluorescent dyes and antibodies, to enhance multicolour flow cytometry capabilities, thereby improving the accuracy and efficiency of immunological research and diagnostics. Bio-Rad has expanded its StarBright Violet Dye series by adding 29 highly validated antibodies conjugated to various StarBright Violet Dyes, which enhances the detection and analysis of multiple cell surface markers in human and animal studies through multicolour flow cytometry. For instance, in May 2024, Bio-Rad Laboratories, Inc., a US-based company specializing in developing and manufacturing advanced technological products, launched three new StarBright Red Dyes: StarBright Red 715, 775, and 815. This expansion increases their existing portfolio of fluorescent dyes to a total of 32 options across multiple lasers, specifically tailored for conventional and full-spectrum flow cytometry applications. Furthermore, these dyes demonstrate minimal background interference compared to traditional cyanine tandem dyes and are stable enough to be fixed in formalin or alcohol-based fixatives without compromising signal integrity.

Innovations in analysis systems, such as imaging analysis systems, provide a competitive edge in the cell surface marker detection market. CytoSMART Technologies BV's launch of CytoSMART Omni FL in April 2022 is an example of this trend. This fluorescence live-cell imaging analysis system, featuring a high-resolution CMOS camera, enables the observation of dynamic cellular processes. Used in various fields, including stem cell biology and immuno-oncology, such technologies contribute to advancing research capabilities and strengthening market competitiveness.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for $2.8 billion. This acquisition is intended to bolster Thermo Fisher Scientific's specialty diagnostics portfolio by improving innovative solutions for blood cancer diagnostics, with a focus on the early diagnosis and effective treatment of multiple myeloma. The Binding Site Group, based in the UK, specializes in researching, developing, manufacturing, and distributing tests for detecting cancers and immune disorders, including flow cytometry.

Major companies operating in the cell surface marker detection market are Thermo Fisher Scientific Inc., Beckman Coulter Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Sartorius, Becton Dickinson and Company, BD Biosciences, Grifols SA, Applied Microarrays Inc., R&D Systems, Agilent Inc., Sigma-Aldrich, Qiagen NV, Sysmex Corporation, Nihon Kohden Corporation, Abnova Corporation, Diasorin SpA, Janssen Diagnostics, Abcam PLC, GenScript Biotech, BioLegend, Cell Signaling Technology Inc., Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Zymo Research Corporation, Miltenyi Biotec

North America was the largest region in the cell surface marker detection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell surface marker detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell surface marker detection market consists of revenues earned by entities by providing cell surface marker detection services such as cell analysis, fluorescence-activated cell sorting (FACS) analysis, immunohistochemistry, blood test, Tbnk test. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell surface marker detection market also includes sales of kits, dyes, analyzers equipment which are used in providing cell surface marker detection services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Surface Marker Detection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell surface marker detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell surface marker detection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell surface marker detection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Flow Cytometry; Hematology Analyzers; Reagents And Kits
• 2) By Application: Disease Diagnosis; Diseases Identification; Research For Drug Discovery; Cytological Academic Research
• 3) By End-Users: Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Testing Laboratories; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Flow Cytometry: Benchtop Flow Cytometers; Portable Flow Cytometers; High-Throughput Flow Cytometers
• 2) By Hematology Analyzers: Automated Hematology Analyzers; Semi-Automated Hematology Analyzers; Point-Of-Care Hematology Analyzers
• 3) By Reagents And Kits: Antibodies And Conjugates; Staining Kits; Calibration And Control Kits
• Companies Mentioned: Thermo Fisher Scientific Inc.; Beckman Coulter Inc.; Siemens Healthineers; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Sartorius; Becton Dickinson and Company; BD Biosciences; Grifols SA; Applied Microarrays Inc.; R&D Systems; Agilent Inc.; Sigma-Aldrich; Qiagen NV; Sysmex Corporation; Nihon Kohden Corporation; Abnova Corporation; Diasorin SpA; Janssen Diagnostics; Abcam PLC; GenScript Biotech; BioLegend; Cell Signaling Technology Inc.; Merck KGaA; Bio-Techne Corporation; Affymetrix; Danaher Corporation; Zymo Research Corporation; Miltenyi Biotec
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.